MedTrace Logo

Radiomics for Tumor Grading of Soft Tissue Sarcomas.

NCT03798795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 285

Last updated 2019-04-10

No results posted yet for this study

Summary

Radiomics is defined as a quantitative high-throughput analysis of imaging data combined with model development aiming to predict biological correlates or clinical endpoints. The investigators of this study hypothesize that radiomic features may correlate with pathology-defined tumor grading in soft tissue sarcoma patients. The aim of this study is to develop a predictive radiomics model for tumor grading determination.

Conditions

  • Sarcoma, Soft Tissue

Sponsors & Collaborators

Principal Investigators

  • Stephanie E Combs, MD · Technical University of Munich

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2018-03-31
Completion
2019-03-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03798795 on ClinicalTrials.gov